Marie-Christine Fluet from Rehaptix pitches at The Brain Forum 2015
About Rehaptix:
ReHaptix, a spin-out from ETH Zürich, Switzerland, is developing an app to monitor and evaluate the progression of upper limb motor function after neurological injury. The app comprises a series of tests that can be performed on a tablet. ReHaptix’s vision is to enable patients to perform the tests at home to continuously self-monitor the progression of their impairments. Patients could then share the data with their healthcare professionals in order to evaluate the effectiveness of their therapy and assess what adaptions may be required to accelerate the patient’s recovery.